Copyright
©The Author(s) 2003.
World J Gastroenterol. Aug 15, 2003; 9(8): 1707-1712
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1707
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1707
Figure 2 eIF-4E protein expression in oligonucleotide-treated colon adenocarcinoma cells.
Protein extracts were prepared from oligonucleotide-treated cells at 48 h after transfection. Cell lysates were size-fractionated by 12% SDS-PAGE, and immunodetection on the blotted membrane was performed using the eIF-4E MAb. AS, antisense oligonucle-otide-treated cells; S. sense oligonucleotide-treated cells; C, cells treated with liposome only; PC, eIF-4E standard anti-gen (derived from a human neuroblastoma cell line) as a positive control marker.
- Citation: Yang YJ, Zhang YL, Li X, Dan HL, Lai ZS, Wang JD, Wang QY, Cui HH, Sun Y, Wang YD. Contribution of eIF-4E inhibition to the expression and activity of heparanase in human colon adenocarcinoma cell line: LS-174T. World J Gastroenterol 2003; 9(8): 1707-1712
- URL: https://www.wjgnet.com/1007-9327/full/v9/i8/1707.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i8.1707